Mesalamine Capsule, Extended Release
Product Images NDC 0378-1375

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0378-1375). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mesalamine Structural Formula (Image 01)

Label for Mesalamine Extended-Release Capsules, USP 0.375 g by Mylan Pharmaceuticals Inc. The front panel shows the product name, strength, dosage form, and quantity of 120 capsules. It includes storage instructions, manufacturer details, a NDC barcode (0378-1375-78), and notes about packaging and child-resistant closures.*

FDA Label Image

Mesalamine Extended-release Capsules, Usp 0.375 G Bottle Label (Image 02)

Chemical structure of mesalamine, showing a benzene ring with an amino group, two hydroxyl groups, and a carboxyl group attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.